Stockreport

Protagonist Therapeutics' stock plunges after colitis treatment trial deemed 'futile' [MarketWatch]

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com
PDF Protagonist Therapeutics' stock plunges after colitis treatment trial deemed 'futile' Protagonist Therapeutics Inc.'s stock PTGX, -58.11% plunged 56% toward a 10-mont [Read more]